mdl 72527 and Disease Exacerbation

mdl 72527 has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amlong, CA; Basu, HS; Church, DR; Clower, CC; Lindstrom, MJ; Martin, CT; Mehraein-Ghomi, F; Thompson, TA; Wilding, G; Woster, PM	1

Other Studies

1 other study(ies) available for mdl 72527 and Disease Exacerbation

Article	Year
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model. Cancer research, 2009, Oct-01, Volume: 69, Issue:19 Topics: Acetyltransferases; Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Male; Mice; Mice, Transgenic; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Prostatic Neoplasms; Putrescine; Reactive Oxygen Species; RNA, Small Interfering	2009

Article

Year

A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.

Cancer research, 2009, Oct-01, Volume: 69, Issue:19

Topics: Acetyltransferases; Adenocarcinoma; Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Humans; Male; Mice; Mice, Transgenic; Oxidative Stress; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Prostatic Neoplasms; Putrescine; Reactive Oxygen Species; RNA, Small Interfering

2009